These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 7034407

  • 1. [Antibodies against tumor associated antigens of human bronchogenic carcinoma: demonstration by anti-complement immunofluorescence (author's transl)].
    Schlipköter HW, Stiller-Winkler R, Idel H, Knopp J.
    Zentralbl Bakteriol Mikrobiol Hyg B; 1981; 174(1-2):105-14. PubMed ID: 7034407
    [Abstract] [Full Text] [Related]

  • 2. [Demonstration of antibodies against tumor-associated antigens in the serum patients with bronchogenic carcinoma using anticomplement immunofluorescence on xenotransplants of human tumors].
    Stiller-Winkler R, Stark M, Idel H.
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Mar; 180(4):381-93. PubMed ID: 2988233
    [Abstract] [Full Text] [Related]

  • 3. [Autoimmunity in patients with bronchogenic carcinomas: occurrence of antibodies against nuclear antigens, chromosomes and ds-deoxyribonucleic acid].
    Dellen H, Seemayer NH.
    Zentralbl Bakteriol Mikrobiol Hyg B; 1983 Sep; 177(6):451-68. PubMed ID: 6322478
    [Abstract] [Full Text] [Related]

  • 4. The recognition of human bronchogenic carcinomas.
    Stark M, Stiller-Winkler R, Idel H, Schlipköter HW.
    Cancer Detect Prev; 1983 Sep; 6(1-2):167-72. PubMed ID: 6883377
    [Abstract] [Full Text] [Related]

  • 5. Anti-tumor antibodies in lung cancer patients. Immunofluorescence study using various indicator cells.
    Górny MK, Jezewska E, Krzyśko R, Stawarz M, Zeromski J.
    Neoplasma; 1979 Sep; 26(6):729-36. PubMed ID: 396479
    [Abstract] [Full Text] [Related]

  • 6. [Immunological diagnosis of bronchogenic carcinoma (author's transl)].
    Schlipköter HW, Idel H, Stiller-Winkler R.
    Prax Klin Pneumol; 1982 Apr; 36(4):198-201. PubMed ID: 7048283
    [No Abstract] [Full Text] [Related]

  • 7. Isolation of lung carcinoma-associated antibodies from immune complexes and production of heterologous antisera.
    Cronin WJ, Dorsett BH, Ioachim HL.
    Cancer Res; 1982 Jan; 42(1):292-300. PubMed ID: 7032694
    [Abstract] [Full Text] [Related]

  • 8. Carcinoembryonic antigen in bronchogenic carcinoma.
    Zatloukal P, Voslárová Z, Mĕricka O, Svarcová H, Schützner J.
    Neoplasma; 1987 Jan; 34(1):73-6. PubMed ID: 3561607
    [Abstract] [Full Text] [Related]

  • 9. Evidence for a common tumour-associated antigen in extracts of human bronchogenic carcinoma.
    Kelly B, Levy JG.
    Br J Cancer; 1977 Jun; 35(6):828-33. PubMed ID: 871369
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of antibody-dependent cell-mediated cytotoxicity (ADCC) as a means of detection of immune complexes in the sera of patients with thyroid disorders and bronchogenic carcinoma.
    Barkas T, AL-Khateeb SF, Irvine WJ, Davidson NM, Roscoe P.
    Clin Exp Immunol; 1976 Aug; 25(2):270-9. PubMed ID: 986262
    [Abstract] [Full Text] [Related]

  • 11. Partial characterization of a fetal lung antigen associated with human bronchogenic carcinoma.
    Sega E, Citro G, Natali PG.
    J Natl Cancer Inst; 1979 May; 62(5):1125-30. PubMed ID: 108444
    [Abstract] [Full Text] [Related]

  • 12. The use of immunoadsorbent columns for the isolation of antibodies specific for antigens associated with human bronchogenic carcinoma.
    Watson RD, Smith AG, Levy JG.
    Br J Cancer; 1974 Mar; 29(3):183-8. PubMed ID: 4208459
    [Abstract] [Full Text] [Related]

  • 13. Microcytotoxicity assays of tumor immunity in patients with bronchogenic carcinoma correlated with clinical status.
    Pierce GE, DeVald B.
    Cancer Res; 1975 Dec; 35(12):3577-84. PubMed ID: 1192421
    [Abstract] [Full Text] [Related]

  • 14. Antibody specific for lung cancer cells detected in sera of patients with bronchogenic carcinoma.
    Yasumoto K, Manabe H, Nomoto K, Inokuchi K.
    Gan; 1983 Aug; 74(4):595-601. PubMed ID: 6628908
    [Abstract] [Full Text] [Related]

  • 15. [Serologic analysis of tumor antibodies in the sera of patients with carcinoma of the larynx (author's transl)].
    Blume N, Milatovic D.
    Laryngol Rhinol Otol (Stuttg); 1981 Aug; 60(8):405-6. PubMed ID: 7346674
    [Abstract] [Full Text] [Related]

  • 16. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
    Brenner BG, Jothy S, Shuster J, Fuks A.
    Cancer Res; 1982 Aug; 42(8):3187-92. PubMed ID: 7046919
    [Abstract] [Full Text] [Related]

  • 17. Antibody in sera of pulmonary cancer patients against specific surface antigen of oat cells.
    Oboshi S, Seido T, Tsugawa S.
    Gan; 1971 Dec; 62(6):515-22. PubMed ID: 4334635
    [No Abstract] [Full Text] [Related]

  • 18. The prognostic value of immunofluorescence from oral swabs in patients with tonsillar carcinoma.
    Mang WL, Hammer C.
    J Med; 1981 Dec; 12(6):447-53. PubMed ID: 7033427
    [Abstract] [Full Text] [Related]

  • 19. Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: an association with type I anti-neuronal nuclear antibodies.
    Dropcho EJ, King PH.
    Ann Neurol; 1994 Aug; 36(2):200-5. PubMed ID: 8053656
    [Abstract] [Full Text] [Related]

  • 20. Tumour-associated antibodies against renal cell carcinomas detected by immunofluorescence.
    Ackermann R.
    Eur Urol; 1975 Aug; 1(3):154-6. PubMed ID: 786650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.